山羊F(ab')2抗人IgG (Fab')2 (Alkaline Phosphatase) (ab98532)
Key features and details
- Goat F(ab')2 Anti-Human IgG (Fab')2 (Alkaline Phosphatase)
- Conjugation: Alkaline Phosphatase
- Host species: Goat
- Isotype: IgG
- Suitable for: ICC, IHC-P, ELISA, WB
Related conjugates and formulations
概述
-
产品名称
山羊F(ab')2抗人IgG (Fab')2 (Alkaline Phosphatase)
参阅全部 IgG 二抗 -
宿主
Goat -
靶标种属
Human -
经测试应用
适用于: ICC, IHC-P, ELISA, WBmore details -
偶联物
Alkaline Phosphatase
性能
-
形式
Liquid -
存放说明
Shipped at 4°C. Store at +4°C. -
存储溶液
pH: 6.8
Preservative: 0.09% Sodium azide
Constituents: 0.00136% Zinc chloride, 1.19% HEPES, 0.2% BSA, 0.58% Sodium chloride, 0.0095% Magnesium chloride -
Concentration information loading...
-
纯度
Immunogen affinity purified -
纯化说明
This antibody was isolated by affinity chromatography using antigen coupled to agarose beads. F(ab')2 fragment were generated using a pepsin digestion. Fc fragments and whole IgG molecules have been removed. Fragments were conjugated to Alkaline Phosphatase. -
克隆
多克隆 -
同种型
IgG -
研究领域
应用
The Abpromise guarantee
Abpromise™承诺保证使用ab98532于以下的经测试应用
“应用说明”部分 下显示的仅为推荐的起始稀释度;实际最佳的稀释度/浓度应由使用者检定。
应用 | Ab评论 | 说明 |
---|---|---|
ICC |
Use at an assay dependent dilution.
|
|
IHC-P |
1/100 - 1/1000.
|
|
ELISA |
1/1000 - 1/10000. (Primary)
|
|
WB |
1/1000 - 1/10000. (Chemiluminescent)
|
说明 |
---|
ICC
Use at an assay dependent dilution. |
IHC-P
1/100 - 1/1000. |
ELISA
1/1000 - 1/10000. (Primary) |
WB
1/1000 - 1/10000. (Chemiluminescent) |
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
Datasheet download
文献 (3)
ab98532 被引用在 3 文献中.
- Guo H et al. Structures of Omicron spike complexes and implications for neutralizing antibody development. Cell Rep 39:110770 (2022). PubMed: 35477022
- Li T et al. Potent SARS-CoV-2 neutralizing antibodies with protective efficacy against newly emerged mutational variants. Nat Commun 12:6304 (2021). PubMed: 34728625
- Gao F et al. A Highly Conserved Peptide Vaccine Candidate Activates Both Humoral and Cellular Immunity Against SARS-CoV-2 Variant Strains. Front Immunol 12:789905 (2021). PubMed: 34950151